康宁杰瑞制药-B回购5.6万股股份,耗资约36.70万港元

公告速递
Nov 05

康宁杰瑞制药-B于2026年11月5日发布翌日报表,公告显示公司于当日通过香港联交所场内回购普通股合计56,000股,占回购前已发行股本约0.0058%。最高每股回购价为6.60港元,最低回购价为6.39港元,合计耗资约36.70万港元。

本次回购完成后,公司于当日的已发行股本(不包括库藏股)降至965,705,697股,库藏股数量增至8,676,000股。公告同时披露,公司回购授权于2026年6月12日通过,可回购股数上限为96,850,669股,至今公司已合计回购股份2,801,000股。

公司确认相关回购行为符合香港联交所证券上市规则及相关法律法规。本次公告由公司执行董事徐霆签署。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10